Approval · Notice of Compliance 31325 · 2023
ZOCOR: Notice of Compliance 31325
Issued July 28, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31325
- Date
- July 28, 2023
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph . Updates to the package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOCOR | Not yet assigned | — |
Medicinal ingredients
- SIMVASTATIN 10 MG per TAB
- SIMVASTATIN 20 MG per TAB
- SIMVASTATIN 40 MG per TAB